News summary

[Brother Technologywemadenewnftgame: The wholly-owned subsidiary obtained CEP certificate for iopamidol API] Securities Times e Company NewswemadenewnftgameBrother Technology (002562) announced on the evening of May 19 that its wholly-owned subsidiary Brother Pharmaceutical recently received the European Pharmacopoeia Suitability Certificate (referred to as "C") issued by the European Agency for the Quality of Medicineswemadenewnftgame.wemadenewnftgame..

Newsletter text

[Brother Technology: The wholly-owned subsidiary obtains CEP certificate for iopamidol API] Securities Times e Company News, Brother Technology (002562) announced on the evening of May 19 that the wholly-owned subsidiary Brother Pharmaceutical recently received a certificate of suitability for the API issued by the European Administration for the Quality of Medicines.(referred to as the "CEP Certificate"), the name of the API is IOPAMIDOL/Iopamidol, which indicates that the company's API can be sold in international markets that recognize the CEP certificate. Iopamidol is mainly used clinically for lumbar, thoracic and cervical myelography, cerebral angiography, peripheral arterial and venous angiography, cardiovascular angiography, coronary angiography, urography, arthrography and CT enhanced scanning.